Synteract Launches Rare Disease Institute

February 28, 2020
Applied Clinical Trials

Synteract has launched the Synteract Rare Disease Institute. The program incorporates lectures, webinars, interactive discussions, videos, and industry literature that cover a wide variety of topics from patient perspectives, bioethics to customer engagement and more.

For more information, click here.